Cirrhosis Latest Advances

Erratum to 'Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017-2023' [Clin Mol Hepatol 2025;31:e235-e238].

Journal: Clinical and molecular hepatology

Published: October 20, 2025

Current Status and Future Directions in the Pharmacologic Management of Cirrhosis.

Journal: Clinics in liver disease

Published: October 18, 2025

Artificial Intelligence and Machine Learning Applications in Liver Disease.

Journal: Clinics in liver disease

Published: October 18, 2025

An uncommon case of hepatocellular carcinoma associated with secondary biliary cirrhosis

Journal: Medicina

Published: October 18, 2025

Recent Advances in Primary Biliary Cholangitis Treatment.

Journal: Clinics in liver disease

Published: October 18, 2025

Associations Between Inflammatory Adipokines, Liver Steatosis, and Fibrosis in Patients with Different Degrees of Adiposity with or Without Metabolic Syndrome.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: October 17, 2025

Shear wave speed reconstruction via combining virtual rotation and directional filtering for enhanced tissue characterization.

Journal: Physics in medicine and biology

Published: October 17, 2025

Bedside FibroScan as a Point-of-care Tool for Quantification for Cirrhosis: A Single-center Prospective Observational Study from Western India.

Journal: The Journal of the Association of Physicians of India

Published: October 16, 2025

The association of systemic inflammatory response syndrome with 30-day mortality in critically ill cirrhosis patients with acute kidney injury: An analysis of the Medical Information Mart for Intensive Care-IV database.

Journal: Science progress

Published: October 15, 2025

XGBoost- and Mass Spectrometry-Based Feature Selection for Identifying Metabolic Biomarkers Associated with HBV-Related Liver Disease Progression and Hepatocellular Carcinoma Treatment.

Journal: Journal of proteome research

Published: October 15, 2025

Anti-hepatic fibrosis effect and mechanism of Albiziae Cortex-Tribuli Fructus based on Nrf2/NLRP3/caspase-1 pathway

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: October 14, 2025

Mechanism of traditional Chinese medicine treatment of hepatic fibrosis by restoring circadian rhythms

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: October 14, 2025

Filters

Erratum to 'Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017-2023' [Clin Mol Hepatol 2025;31:e235-e238].

Erratum to 'Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017-2023' [Clin Mol Hepatol 2025;31:e235-e238].

Current Status and Future Directions in the Pharmacologic Management of Cirrhosis.

Current Status and Future Directions in the Pharmacologic Management of Cirrhosis.

Artificial Intelligence and Machine Learning Applications in Liver Disease.

Artificial Intelligence and Machine Learning Applications in Liver Disease.

An uncommon case of hepatocellular carcinoma associated with secondary biliary cirrhosis

An uncommon case of hepatocellular carcinoma associated with secondary biliary cirrhosis

Recent Advances in Primary Biliary Cholangitis Treatment.

Recent Advances in Primary Biliary Cholangitis Treatment.

Associations Between Inflammatory Adipokines, Liver Steatosis, and Fibrosis in Patients with Different Degrees of Adiposity with or Without Metabolic Syndrome.

Associations Between Inflammatory Adipokines, Liver Steatosis, and Fibrosis in Patients with Different Degrees of Adiposity with or Without Metabolic Syndrome.

Shear wave speed reconstruction via combining virtual rotation and directional filtering for enhanced tissue characterization.

Shear wave speed reconstruction via combining virtual rotation and directional filtering for enhanced tissue characterization.

Bedside FibroScan as a Point-of-care Tool for Quantification for Cirrhosis: A Single-center Prospective Observational Study from Western India.

Bedside FibroScan as a Point-of-care Tool for Quantification for Cirrhosis: A Single-center Prospective Observational Study from Western India.

The association of systemic inflammatory response syndrome with 30-day mortality in critically ill cirrhosis patients with acute kidney injury: An analysis of the Medical Information Mart for Intensive Care-IV database.

The association of systemic inflammatory response syndrome with 30-day mortality in critically ill cirrhosis patients with acute kidney injury: An analysis of the Medical Information Mart for Intensive Care-IV database.

XGBoost- and Mass Spectrometry-Based Feature Selection for Identifying Metabolic Biomarkers Associated with HBV-Related Liver Disease Progression and Hepatocellular Carcinoma Treatment.

XGBoost- and Mass Spectrometry-Based Feature Selection for Identifying Metabolic Biomarkers Associated with HBV-Related Liver Disease Progression and Hepatocellular Carcinoma Treatment.

Anti-hepatic fibrosis effect and mechanism of Albiziae Cortex-Tribuli Fructus based on Nrf2/NLRP3/caspase-1 pathway

Anti-hepatic fibrosis effect and mechanism of Albiziae Cortex-Tribuli Fructus based on Nrf2/NLRP3/caspase-1 pathway

Mechanism of traditional Chinese medicine treatment of hepatic fibrosis by restoring circadian rhythms

Mechanism of traditional Chinese medicine treatment of hepatic fibrosis by restoring circadian rhythms